Min, Sherene <br/><br/>
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.  [electronic resource] 

 -  AIDS (London, England)  Sep 2011 
 - 1737-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e32834a1dd9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Area Under Curve<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Heterocyclic Compounds, 3-Ring--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Oxazines<br/>Piperazines<br/>Pyridones<br/>Treatment Outcome